Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative […]

In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and

Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool

Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. **Pfizer’s Elrexfio**: Recommended in England for multiple

Here’s a simplified summary of the recent news from Biogen, Novartis, Resalis Therapeutics, and Moderna: **Biogen**: The biotech company has

At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the

GSK, a pharmaceutical company, is spending $300 million to buy a special type of drug from Chimagen Biosciences, a company

The FDA has given special status to a new treatment called MDL-101 by Modalis Therapeutics for a rare muscle disorder

Pfizer recently reported strong earnings for the third quarter, surpassing Wall Street expectations. As a result, the company has increased

Ultra-processed foods (UPFs) are linked to health issues like obesity, diabetes, heart disease, and some cancers. In India, obesity rates